Alendronate and raloxifene affect the osteoprotegerin/RANKL system in human osteoblast primary cultures from patients with osteoporosis and osteoarthritis
Author:
Publisher
Elsevier BV
Subject
Pharmacology
Reference44 articles.
1. Changes in RANKL/osteoprotegerin/RANK gene expression in peripheral mononuclear cells following treatment with estrogen or raloxifene;Bashir;Steroids,2005
2. Effects of genistein aglycone in osteoporotic, ovariectomized rats: a comparison with alendronate, raloxifene and oestradiol;Bitto;Br. J. Pharmacol.,2008
3. Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene;Cheung;J. Endocrinol.,2003
4. Sex steroids and bone;Compston;Physiol. Rev.,2001
5. Differential effects of teriparatide on bone mineral density after treatment with raloxifene or alendronate;Ettinger;J. Bone Miner. Res.,2004
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Enhanced osteogenic differentiation of alendronate-conjugated nanodiamonds for potential osteoporosis treatment;Biomaterials Research;2021-09-23
2. Randomized head-to-head comparison of minodronic acid and raloxifene for fracture incidence in postmenopausal Japanese women: the Japanese Osteoporosis Intervention Trial (JOINT)-04;Current Medical Research and Opinion;2020-09-14
3. Long-term evaluation of alendronate treatment on the healing of calvaria bone defects in rats. Biochemical, histological and immunohistochemical analyses;Archives of Oral Biology;2020-09
4. Do antiosteoporotic drugs improve bone regeneration in vivo?;European Journal of Trauma and Emergency Surgery;2019-04-26
5. Beneficial Effects of Concentrated Growth Factors and Resveratrol on Human Osteoblasts In Vitro Treated with Bisphosphonates;BioMed Research International;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3